Emergency Zika Vaccine Could be Ready by October

A vaccine for the Zika virus, being developed by a consortium, including Inovio Pharmaceuticals, Inc.

, could be ready for emergency use by October,

on Thursday. The vaccine is being developed by U.S. and Canadian scientists and could be ready for human trials by September, subject to regulatory approval. A collaboration on development of a Zika virus vaccine between Inovio and Korea's GeneOne Life Science was

. Inovio closed Thursday at $5.78, up $0.41.